Edition:
United States

GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,480.00GBp
14 Dec 2018
Change (% chg)

-2.20 (-0.15%)
Prev Close
1,482.20
Open
1,467.40
Day's High
1,486.60
Day's Low
1,463.20
Volume
6,716,347
Avg. Vol
8,244,466
52-wk High
1,648.80
52-wk Low
1,235.20

Chart for

About

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare... (more)

Overall

Beta: 1.21
Market Cap(Mil.): £75,181.28
Shares Outstanding(Mil.): 4,918.63
Dividend: 19.00
Yield (%): --

Financials

  GSK.L Industry Sector
P/E (TTM): 38.75 31.13 34.39
EPS (TTM): 0.39 -- --
ROI: 7.58 15.55 14.96
ROE: 278.84 16.92 16.52

Class certified in Lamictal antitrust case against GSK, Teva

Purchasers of GlaxoSmithKline PLC's anti-seizure drug Lamictal have won class certification for an antitrust lawsuit claiming the drugmaker conspired with Teva Pharmaceutical Industries Ltd to delay the latter's generic version.

Dec 13 2018

Collapse of Tesco re-trial casts cloud over British fraud agency

LONDON The UK Serious Fraud Office (SFO) defended itself on Thursday against criticisms of "serious failings" after the collapse of a high-profile re-trial of former Tesco executives, insisting the prosecution had been in the public interest.

Dec 06 2018

Collapse of Tesco re-trial casts cloud over British fraud agency

* SFO must weed out "evidentially flawed" historic cases - lawyer

Dec 06 2018

Relief rally boosts Wall Street on U.S.-China trade truce

Wall Street's major indexes rallied on Monday following a truce between the United States and China in their trade dispute, which has clouded the outlook for the stock market for much of the year. | Video

Dec 03 2018

US STOCKS-Relief rally boosts Wall Street on U.S.-China trade truce

(For a live blog on the U.S. stock market, click or type LIVE/ in an Eikon news window.) * U.S., China agree on a trade ceasefire for talks * Technology, industrials sectors support S&P * Energy shares jump as oil prices rebound * Tesaro shares soar on Glaxo buyout deal * Indexes up: Dow 1.13 pct, S&P 1.09 pct, Nasdaq 1.51 pct (Updates with close of U.S. trading) By Lewis Krauskopf Dec 3 Wall Street's major indexes rallied on Monday following a

Dec 03 2018

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion

LONDON GlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion, a costly investment to rebuild the pharmaceuticals business by new Chief Executive Emma Walmsley that unnerved investors. | Video

Dec 03 2018

Deals of the day-Mergers and acquisitions

Dec 3 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

Dec 03 2018

U.S.-China trade truce triggers European share surge

LONDON Miners, autos, tech, and oil stocks surged on Monday, driving Europe's main benchmarks up strongly after U.S. and Chinese leaders agreed a temporary truce in a trade war.

Dec 03 2018

UPDATE 3-GSK slides after buying cancer firm Tesaro for hefty $5.1 bln

* GSK shares see biggest daily fall in 10 years (Adds latest shares, termination fee, more on drug competition)

Dec 03 2018

Monday Morning Briefing

The truce between U.S. and Chinese leaders on trade tariffs has fuelled a nearly one percent surge on world stocks, GlaxoSmithKline agrees to buy U.S. cancer drug specialist Tesaro for $5.1 billion and Qatar takes a swipe at Saudi Arabia, OPECS's de facto leader, by announcing that it will be leaving the group in January. Catch up on the latest headlines.

Dec 03 2018

Earnings vs. Estimates